Skip to main content

07.02.2024 | Review

Primary Pancreatic GIST — A-Single Centre Case Series and Systematic Review of Literature

verfasst von: Vipul Gupta, Amit Chopde, Vikram Chaudhari, Munita Bal, Shailesh V. Shrikhande, Manish S. Bhandare

Erschienen in: Journal of Gastrointestinal Cancer

Einloggen, um Zugang zu erhalten

Abstract

Purpose

GISTs arising from organs outside GI tract are defined as extragastrointestinal GISTs (EGIST). The majority of EGISTs arise from small intestinal mesentry, mesocolon, omentum, retroperitoneum, abdominal wall, liver and pancreas with pancreas comprising less than 5% of it. Due to limited data, it is unknown if the results of GIST can be generalised for EGISTs. We thereby present the largest single-centre case series of primary pancreatic GIST so far with review of existing literature.

Methods

A total of 9 patients of primary pancreatic GIST were treated at our institute from September 2016 to February 2023. After literature search for all studies published before February 2023, 51 articles including 57 patients were identified. Their clinicopathological data and survival analysis were assessed.

Results

The median age of patients treated at our centre was 53 years with a female predominance. The most common epicentre was pancreatic head with abdominal pain as the most common presenting symptom. All 57 patients documented in literature belonged to a similar age group with similar gender predilection. The factors impacting DFS were histologic type, mitotic index, NIH risk category and adjuvant therapy. The median DFS was 74 months with a 5-year DFS being 71.9%, while the 5-year OS was 90.4%.

Conclusion

Pancreatic GIST is a rare entity. Due to limited evidence and evolving literature, results cannot be generalised to a larger population. Larger case series with longer follow-up data are required to further understand the disease biology and long-term outcomes of pancreatic GIST.
Literatur
2.
Zurück zum Zitat Zhou J, Yan T, Huang Z, Zhao J, Bi X, Zhao H, Zhang YF, Cai J. Clinical features and prognosis of extragastrointestinal stromal tumors. Int J Clin Exp Med. 2016;9(8):16367–72. Zhou J, Yan T, Huang Z, Zhao J, Bi X, Zhao H, Zhang YF, Cai J. Clinical features and prognosis of extragastrointestinal stromal tumors. Int J Clin Exp Med. 2016;9(8):16367–72.
3.
Zurück zum Zitat Padhi S, Sarangi R, Mallick S. Pancreatic extragastrointestinal stromal tumors, interstitial Cajal like cells, and telocytes. JOP. 2013;14:1–14. [PubMed] [Google Scholar].PubMed Padhi S, Sarangi R, Mallick S. Pancreatic extragastrointestinal stromal tumors, interstitial Cajal like cells, and telocytes. JOP. 2013;14:1–14. [PubMed] [Google Scholar].PubMed
8.
Zurück zum Zitat Barros A, Linhares E, Valadão M, Gonçalves R, Vilhena B, Gil C, Ramos C. Extragastrointestinal stromal tumors (EGIST): a series of case reports. Hepatogastroenterology. 2011;58:865–8. PMID: 21830406.PubMed Barros A, Linhares E, Valadão M, Gonçalves R, Vilhena B, Gil C, Ramos C. Extragastrointestinal stromal tumors (EGIST): a series of case reports. Hepatogastroenterology. 2011;58:865–8. PMID: 21830406.PubMed
9.
Zurück zum Zitat Goh BK, Chow PK, Kesavan SM, Yap WM, Chung YF, Wong WK. A single-institution experience with eight CD117- positive primary extragastrointestinal stromal tumors: critical appraisal and a comparison with their gastrointestinal counterparts. J Gastrointest Surg. 2009;13:1094–8. https://doi.org/10.1007/s11605-009-0828-4. PMID: 19238492.CrossRefPubMed Goh BK, Chow PK, Kesavan SM, Yap WM, Chung YF, Wong WK. A single-institution experience with eight CD117- positive primary extragastrointestinal stromal tumors: critical appraisal and a comparison with their gastrointestinal counterparts. J Gastrointest Surg. 2009;13:1094–8. https://​doi.​org/​10.​1007/​s11605-009-0828-4. PMID: 19238492.CrossRefPubMed
10.
Zurück zum Zitat Babu SR, Kumari S, Zhang Y, Su A, Wang W, Tian B. Extra gastrointestinal stromal tumor arising in the pancreas: a case report and literature review. J Gastroenterol Hepatol Res. 2012;1:80–3. Babu SR, Kumari S, Zhang Y, Su A, Wang W, Tian B. Extra gastrointestinal stromal tumor arising in the pancreas: a case report and literature review. J Gastroenterol Hepatol Res. 2012;1:80–3.
12.
Zurück zum Zitat Vij M, Agrawal V, Pandey R. Malignant extra-gastrointestinal stromal tumor of the pancreas. A case report and review of literature. JOP. 2011;12:200–4 PMID: 21386653.PubMed Vij M, Agrawal V, Pandey R. Malignant extra-gastrointestinal stromal tumor of the pancreas. A case report and review of literature. JOP. 2011;12:200–4 PMID: 21386653.PubMed
13.
Zurück zum Zitat Agaimy A, Wünsch PH. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours. Langenbecks Arch Surg. 2006;391(4):322–9. https://doi.org/10.1007/s00423-005-0005-5. Epub 2006 Jan 10. PMID: 16402273.CrossRefPubMed Agaimy A, Wünsch PH. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours. Langenbecks Arch Surg. 2006;391(4):322–9. https://​doi.​org/​10.​1007/​s00423-005-0005-5. Epub 2006 Jan 10. PMID: 16402273.CrossRefPubMed
14.
Zurück zum Zitat Akahoshi K, Sumida Y, Matsui N, Oya M, Akinaga R, Kubokawa M, Motomura Y, Honda K, Watanabe M, Nagaie T. Preoperative diagnosis of gastrointestinal stromal tumour by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol. 2007;13:2077–82.CrossRefPubMedPubMedCentral Akahoshi K, Sumida Y, Matsui N, Oya M, Akinaga R, Kubokawa M, Motomura Y, Honda K, Watanabe M, Nagaie T. Preoperative diagnosis of gastrointestinal stromal tumour by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol. 2007;13:2077–82.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Rutkowski P, Gronchi A, Hohenberger P, et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20(9):2937–43.CrossRefPubMed Rutkowski P, Gronchi A, Hohenberger P, et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20(9):2937–43.CrossRefPubMed
23.
Zurück zum Zitat Castellón CJ, Díaz GA, López P, Paz BA, Morales S, Durán M. Local resection of a pancreatic GIST in the area of the pancreatoduodenal groove. Is the surgical technique a prognostic factor? J Case Rep Images Surg. 2020;6:100080Z12CC2020. Castellón CJ, Díaz GA, López P, Paz BA, Morales S, Durán M. Local resection of a pancreatic GIST in the area of the pancreatoduodenal groove. Is the surgical technique a prognostic factor? J Case Rep Images Surg. 2020;6:100080Z12CC2020.
24.
Zurück zum Zitat Yau I. Pancreatic extragastrointestinal stromal tumor in a patient with neurofibromas presenting with iron deficiency anemia. Case reports. Open Access. 2019;4:1–3. Yau I. Pancreatic extragastrointestinal stromal tumor in a patient with neurofibromas presenting with iron deficiency anemia. Case reports. Open Access. 2019;4:1–3.
25.
Zurück zum Zitat Tounsi N. Primary extragastrointestinal stromal tumor arising In the pancreas: report of a case. IOSR-JDMS. 2018;17(2):20–3.MathSciNet Tounsi N. Primary extragastrointestinal stromal tumor arising In the pancreas: report of a case. IOSR-JDMS. 2018;17(2):20–3.MathSciNet
38.
Zurück zum Zitat Ambrosio MR, Rocca BJ, Mastrogiulio MG, Pesci A, De Martino A, Mazzei MA, Volterrani L, Arcuri F, Cintorino M, Tripodi SA. Cystic gastrointestinal stromal tumors of the pancreas simulating cystoadenocarcinoma. Report of three cases and short review of the literature. Histol Histopathol. 2014;29(12):1583–91. https://doi.org/10.14670/HH-29.1583. Epub 2014 Jun 11. PMID: 24918465.CrossRefPubMed Ambrosio MR, Rocca BJ, Mastrogiulio MG, Pesci A, De Martino A, Mazzei MA, Volterrani L, Arcuri F, Cintorino M, Tripodi SA. Cystic gastrointestinal stromal tumors of the pancreas simulating cystoadenocarcinoma. Report of three cases and short review of the literature. Histol Histopathol. 2014;29(12):1583–91. https://​doi.​org/​10.​14670/​HH-29.​1583. Epub 2014 Jun 11. PMID: 24918465.CrossRefPubMed
40.
Zurück zum Zitat Paklina OV, Setdikova GR, Voskanyan SE. Gastrointestinal stromal tumor of a pancreas: case report and literature review. Meдицинcкaя визyaлизaция. 2013;2:122. Paklina OV, Setdikova GR, Voskanyan SE. Gastrointestinal stromal tumor of a pancreas: case report and literature review. Meдицинcкaя визyaлизaция. 2013;2:122.
43.
Zurück zum Zitat Meng L, Fang SH, Jin M. An unusual case of pancreatic and gastric neoplasms (2010b): malignant GISTs originating from the pancreas and stomach. Eur Radiol. 2011;21(3):663–5.CrossRefPubMed Meng L, Fang SH, Jin M. An unusual case of pancreatic and gastric neoplasms (2010b): malignant GISTs originating from the pancreas and stomach. Eur Radiol. 2011;21(3):663–5.CrossRefPubMed
44.
Zurück zum Zitat Rao RN, Vij M, Singla N, Kumar A. Malignant pancreatic extra-gastrointestinal stromal tumor diagnosed by ultrasound guided fine needle aspiration cytology. A case report with a review of the literature. JOP. 2011;12:283–6 PMID: 21546710.PubMed Rao RN, Vij M, Singla N, Kumar A. Malignant pancreatic extra-gastrointestinal stromal tumor diagnosed by ultrasound guided fine needle aspiration cytology. A case report with a review of the literature. JOP. 2011;12:283–6 PMID: 21546710.PubMed
46.
Zurück zum Zitat Joshi J, Rustagi T. Pancreatic extra-gastrointestinal stromal tumor: an unusual presentation of a rare diagnosis. Gastrointest Cancer Res. 2010;(Suppl 1):S29–30 PMCID: PMC3047023.PubMedCentral Joshi J, Rustagi T. Pancreatic extra-gastrointestinal stromal tumor: an unusual presentation of a rare diagnosis. Gastrointest Cancer Res. 2010;(Suppl 1):S29–30 PMCID: PMC3047023.PubMedCentral
47.
Zurück zum Zitat Crisan A, Nicoara E, Cucui V, Cornea G, Laza R. Prolonged fever associated with gastrointestinal stromal tumor-case report. J Exp Med Surg Res. 2010;17:219–24. Crisan A, Nicoara E, Cucui V, Cornea G, Laza R. Prolonged fever associated with gastrointestinal stromal tumor-case report. J Exp Med Surg Res. 2010;17:219–24.
48.
Zurück zum Zitat Saif MW, Hotchkiss S, Kaley K. Gastrointestinal stromal tumors of the pancreas. JOP. 2010;11:405–6; author reply 412. PMID: 20601822.PubMed Saif MW, Hotchkiss S, Kaley K. Gastrointestinal stromal tumors of the pancreas. JOP. 2010;11:405–6; author reply 412. PMID: 20601822.PubMed
49.
Zurück zum Zitat Harindhanavudhi T, Tanawuttiwat T, Pyle J, Silva R. Extragastrointestinal stromal tumor presenting as hemorrhagic pancreatic cyst diagnosed by EUS-FNA. JOP. 2009;10:189–91. PMID: 19287116.PubMed Harindhanavudhi T, Tanawuttiwat T, Pyle J, Silva R. Extragastrointestinal stromal tumor presenting as hemorrhagic pancreatic cyst diagnosed by EUS-FNA. JOP. 2009;10:189–91. PMID: 19287116.PubMed
50.
Zurück zum Zitat Trabelsi A, Yacoub-Abid LB, Mtimet A, Abdelkrim SB, Hammedi F, Ali AB, Mokni M. Gastrointestinal stromal tumor of the pancreas: a case report and review of the literature. N Am J Med Sci. 2009;1:324–6. PMID: 22666718.PubMedPubMedCentral Trabelsi A, Yacoub-Abid LB, Mtimet A, Abdelkrim SB, Hammedi F, Ali AB, Mokni M. Gastrointestinal stromal tumor of the pancreas: a case report and review of the literature. N Am J Med Sci. 2009;1:324–6. PMID: 22666718.PubMedPubMedCentral
52.
Zurück zum Zitat Yan BM, Pai RK, Van Dam J. Diagnosis of pancreatic gastrointestinal stromal tumor by EUS guided FNA. JOP. 2008;9:192–6. PMID: 18326928.PubMed Yan BM, Pai RK, Van Dam J. Diagnosis of pancreatic gastrointestinal stromal tumor by EUS guided FNA. JOP. 2008;9:192–6. PMID: 18326928.PubMed
53.
Zurück zum Zitat Ganesh M, Kumar S, Krishnamoorthy R, Ang Y. Rare cause of pancreatic mass responding to imatinib treatment. Gastroenterology Today. 2008;18:50–1. Ganesh M, Kumar S, Krishnamoorthy R, Ang Y. Rare cause of pancreatic mass responding to imatinib treatment. Gastroenterology Today. 2008;18:50–1.
55.
Zurück zum Zitat Krska Z, Pesková M, Povýsil C, Horejs J, Sedlácková E, Kudrnová Z. GIST of pancreas. Prague Med Rep. 2005;106:201–8. PMID: 16315768.PubMed Krska Z, Pesková M, Povýsil C, Horejs J, Sedlácková E, Kudrnová Z. GIST of pancreas. Prague Med Rep. 2005;106:201–8. PMID: 16315768.PubMed
59.
Zurück zum Zitat Boyer C, Duvet S, Wacrenier A, Toursel H, et al. Leiomyosarcoma and stromal tumor of the pancreas. J Radiol. 2001;82:1723–5.PubMed Boyer C, Duvet S, Wacrenier A, Toursel H, et al. Leiomyosarcoma and stromal tumor of the pancreas. J Radiol. 2001;82:1723–5.PubMed
Metadaten
Titel
Primary Pancreatic GIST — A-Single Centre Case Series and Systematic Review of Literature
verfasst von
Vipul Gupta
Amit Chopde
Vikram Chaudhari
Munita Bal
Shailesh V. Shrikhande
Manish S. Bhandare
Publikationsdatum
07.02.2024
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-024-01024-8

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.